A. D. Roberts

发表

Novel squalestatin derivatives arising from reactions at the allylic centre of the C1-side chain

B. Dymock, P. Sidebottom, P. Procopiou, 1998 .

New class of mixed sandwich cycloheptatrienylchromium complex: crystal structures of the redox pair [Cr(η-C6H5Me)(η-C7H6C6H4Me-4)][PF6]n(n= 1 or 2)

E. McInnes, R. L. Beddoes, A. Roberts, 1996 .

Eryloside F, a novel penasterol disaccharide possessing potent thrombin receptor antagonist activity.

P. S. Robinson, S. Pomponi, N. Pike, 2000, Bioorganic & medicinal chemistry letters.

A Qualified Success: Discovery of a New Series of ATAD2 Bromodomain Inhibitors with a Novel Binding Mode Using High-Throughput Screening and Hit Qualification.

P. Grandi, A. Michon, Christina Rau, 2019, Journal of medicinal chemistry.

1,3-Dimethyl Benzimidazolones Are Potent, Selective Inhibitors of the BRPF1 Bromodomain.

David J. Fallon, P. Grandi, A. Michon, 2014, ACS medicinal chemistry letters.

Development of a Scalable Process for the PPAR-α Agonist GW641597X Incorporating Baeyer–Villiger Chemistry and Retrospective ICH M7 Assessment

Neil G. Stevenson, Stephen K. Etridge, Neil S. Hodnett, 2020 .

Use of Phosphazene Base BTPP for Phosphorylative Activation in the Scale-Up of BET Inhibitor GSK525762

Sheryl M. Davies, A. Roberts, I. Mann, 2022, Organic Process Research & Development.

Fragment-Based Discovery of Low-Micromolar ATAD2 Bromodomain Inhibitors.

P. Grandi, A. Michon, P. Bamborough, 2015, Journal of medicinal chemistry.

Novel secosteroids arising from acid catalysed rearrangement of fluocinonide acetonide in the presence of Tf2O and TMSOTf

S. Lynn, P. Procopiou, A. D. Roberts, 1999 .